SG11202103215SA - Treatment of myopia and other ocular conditions using singlet oxygen - Google Patents

Treatment of myopia and other ocular conditions using singlet oxygen

Info

Publication number
SG11202103215SA
SG11202103215SA SG11202103215SA SG11202103215SA SG11202103215SA SG 11202103215S A SG11202103215S A SG 11202103215SA SG 11202103215S A SG11202103215S A SG 11202103215SA SG 11202103215S A SG11202103215S A SG 11202103215SA SG 11202103215S A SG11202103215S A SG 11202103215SA
Authority
SG
Singapore
Prior art keywords
myopia
treatment
singlet oxygen
ocular conditions
ocular
Prior art date
Application number
SG11202103215SA
Inventor
John Jarman
Dennis Dougherty
Robert Grubbs
Christopher Marotta
Daniel Schwartz
Original Assignee
California Inst Of Techn
Univ California
Us Gov Represented By The Department Of Veterans Affairs
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by California Inst Of Techn, Univ California, Us Gov Represented By The Department Of Veterans Affairs filed Critical California Inst Of Techn
Publication of SG11202103215SA publication Critical patent/SG11202103215SA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B23/00Methine or polymethine dyes, e.g. cyanine dyes
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B23/00Methine or polymethine dyes, e.g. cyanine dyes
    • C09B23/0008Methine or polymethine dyes, e.g. cyanine dyes substituted on the polymethine chain
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B23/00Methine or polymethine dyes, e.g. cyanine dyes
    • C09B23/0066Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain being part of a carbocyclic ring,(e.g. benzene, naphtalene, cyclohexene, cyclobutenene-quadratic acid)
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B23/00Methine or polymethine dyes, e.g. cyanine dyes
    • C09B23/02Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups
    • C09B23/08Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups more than three >CH- groups, e.g. polycarbocyanines
    • C09B23/083Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups more than three >CH- groups, e.g. polycarbocyanines five >CH- groups
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09BORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
    • C09B23/00Methine or polymethine dyes, e.g. cyanine dyes
    • C09B23/02Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups
    • C09B23/08Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups more than three >CH- groups, e.g. polycarbocyanines
    • C09B23/086Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups more than three >CH- groups, e.g. polycarbocyanines more than five >CH- groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11202103215SA 2018-10-24 2019-10-23 Treatment of myopia and other ocular conditions using singlet oxygen SG11202103215SA (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201862750095P 2018-10-24 2018-10-24
US201962797068P 2019-01-25 2019-01-25
US201962877101P 2019-07-22 2019-07-22
PCT/US2019/057622 WO2020086697A1 (en) 2018-10-24 2019-10-23 Treatment of myopia and other ocular conditions using singlet oxygen

Publications (1)

Publication Number Publication Date
SG11202103215SA true SG11202103215SA (en) 2021-05-28

Family

ID=70328129

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202103215SA SG11202103215SA (en) 2018-10-24 2019-10-23 Treatment of myopia and other ocular conditions using singlet oxygen

Country Status (6)

Country Link
US (2) US20200129620A1 (en)
JP (1) JP2022503941A (en)
KR (1) KR20210093901A (en)
CN (1) CN113286788A (en)
SG (1) SG11202103215SA (en)
WO (1) WO2020086697A1 (en)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007536272A (en) * 2004-05-07 2007-12-13 ザ・レジェンツ・オブ・ザ・ユニバーシティ・オブ・カリフォルニア Myopia treatment
US20060239916A1 (en) * 2005-01-07 2006-10-26 Kai Licha Use of cyanine dyes for the diagnosis of proliferative diseases
JPWO2009107769A1 (en) * 2008-02-29 2011-07-07 国立大学法人 東京大学 Reactive oxygen measurement reagent
WO2009146151A2 (en) * 2008-04-04 2009-12-03 Forsight Labs, Llc Corneal onlay devices and methods
KR101572634B1 (en) * 2008-04-04 2015-12-01 포사이트 비젼4, 인크. Therapeutic device for pain management and vision
US8772376B2 (en) * 2009-08-18 2014-07-08 International Business Machines Corporation Near-infrared absorbing film compositions
IN2014CN02153A (en) * 2011-08-23 2015-05-29 Yeda Res & Dev
CN110730672A (en) * 2017-04-12 2020-01-24 奥拉生物科学公司 Targeted combination therapy

Also Published As

Publication number Publication date
US20200129620A1 (en) 2020-04-30
KR20210093901A (en) 2021-07-28
US20230173071A1 (en) 2023-06-08
JP2022503941A (en) 2022-01-12
WO2020086697A1 (en) 2020-04-30
CN113286788A (en) 2021-08-20

Similar Documents

Publication Publication Date Title
EP3554401A4 (en) Ocular treatment devices and related methods of use
EP3749264C0 (en) Laser therapy for treatment and prevention of eye diseases
EP3920923A4 (en) Therapeutic agents and methods of treatment
IL276383A (en) Treatment of ophthalmologic diseases
EP3463315C0 (en) Compositions and methods of using nintedanib for treating ocular diseases with abnormal neovascularization
SG11202010472XA (en) Use of pilocarpine hydrochloride for the treatment of ocular conditions
EP3829569A4 (en) Spinosyn formulations for treatment of demodex-induced ocular and facial conditions
SG11202103033WA (en) Compositions and methods for the treatment of presbyopia
EP3833340A4 (en) Compositions and methods for treatment of presbyopia
IL287280A (en) Compounds and methods for the treatment of ocular disorders
IL289405A (en) Personalized treatment of ophthalmologic diseases
EP3735209A4 (en) Treatment of myopic progression
IL287594A (en) Compositions and methods for the treatment of retinal degeneration
IL287264A (en) Compounds and methods for the treatment of ocular disorders
EP3713553A4 (en) Compositions and methods for treatment of eye diseases
EP3644966A4 (en) Treatment and diagnosis of ocular surface disorders
IL272121A (en) Composition and methods for the treatment of myopia
IL269698B (en) Methods of preventing or treating ophthalmic diseases
GB202015959D0 (en) Treatment of diseases involving NAD
EP4017493A4 (en) Methods of treatment using bcn057 and bcn512
SG11202012473UA (en) Ophthalmic compositions and methods for the treatment of eye disorders
IL282898A (en) Ophthalmic compositions and methods for the treatment of skin diseases and eye diseases
SG11202103215SA (en) Treatment of myopia and other ocular conditions using singlet oxygen
IL280588A (en) Ophthalmic compositions and methods for the treatment of eye disorders and skin diseases
EP3787749A4 (en) Methods of treating retinal diseases